☰

Katerina D. Fagan-Solis, Ph.D. - Publications

Affiliations: 
2013 Molecular & Cellular Biology University of Massachusetts, Amherst, Amherst, MA 
Area:
Molecular Biology, Oncology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Fagan-Solis KD, Simpson DA, Kumar RJ, Martelotto LG, Mose LE, Rashid NU, Ho AY, Powell SN, Wen YH, Parker JS, Reis-Filho JS, Petrini JHJ, Gupta GP. A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability. Cell Reports. 30: 1385-1399.e7. PMID 32023457 DOI: 10.1016/J.Celrep.2020.01.020  0.421
2016 Reaves DK, Hoadley KA, Fagan-Solis K, Jima DD, Bereman M, Thorpe L, Hicks J, McDonald D, Troester MA, Perou CM, Fleming JM. Nuclear localized LSR, a novel regulator of breast cancer behavior and tumorigenesis. Molecular Cancer Research : McR. PMID 27856957 DOI: 10.1158/1541-7786.Mcr-16-0085-T  0.588
2015 Fagan-Solis KD, McDonald DA, Thorpe LW, Fleming JM. Abstract 1193: LSR transcript variant iota drives nuclear localization and altered transcriptome regulation in breast cancer Cancer Research. 75: 1193-1193. DOI: 10.1158/1538-7445.Am2015-1193  0.706
2014 Fagan-Solis KD, Reaves DK, Rangel MC, Popoff MR, Stiles BG, Fleming JM. Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer. Molecular Cancer. 13: 163. PMID 24990559 DOI: 10.1186/1476-4598-13-163  0.729
2014 Reaves DK, Fagan-Solis KD, Dunphy K, Oliver SD, Scott DW, Fleming JM. The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior. Plos One. 9: e91747. PMID 24637461 DOI: 10.1371/Journal.Pone.0091747  0.803
2014 Fagan-Solis KD, Pentecost BT, Gozgit JM, Bentley BA, Marconi SM, Otis CN, Anderton DL, Schneider SS, Arcaro KF. SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer. Journal of Cellular Physiology. 229: 1160-9. PMID 24443386 DOI: 10.1002/Jcp.24545  0.656
2014 Fleming JM, Reaves DK, Fagan-Solis KD, Dunphy K, Oliver SD. Abstract 1987: The role of lipolysis-stimulated lipoprotein receptor in directing breast cancer cell behavior and subtype Cancer Research. 74: 1987-1987. DOI: 10.1158/1538-7445.Am2014-1987  0.792
2013 Fagan-Solis KD, Schneider SS, Pentecost BT, Bentley BA, Otis CN, Gierthy JF, Arcaro KF. The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line. Journal of Cellular Biochemistry. 114: 1385-94. PMID 23255405 DOI: 10.1002/Jcb.24480  0.754
2013 Fagan-Solis KD, Gogzit JM, Bentley BA, Marconi SM, Otis CN, Anderton DL, Schneider SS, Pentecost BT, Arcaro KF. Abstract 563: SKP2 overexpression is associated with increased serine-10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancers. Cancer Research. 73: 563-563. DOI: 10.1158/1538-7445.Am2013-563  0.806
2012 Turk CM, Fagan-Solis KD, Williams KE, Gozgit JM, Smith-Schneider S, Marconi SA, Otis CN, Crisi GM, Anderton DL, Kilimann MW, Arcaro KF. Paralemmin-1 is over-expressed in estrogen-receptor positive breast cancers. Cancer Cell International. 12: 17. PMID 22574838 DOI: 10.1186/1475-2867-12-17  0.64
2011 Fagan-Solis KD, Smith-Schneider S, Arcaro KF. Abstract 1403: Inhibiting the Rho pathway in the triple-negative, basal-like breast cancer cell line, TMX2-28, inhibits invasive behavior Cancer Research. 71: 1403-1403. DOI: 10.1158/1538-7445.Am2011-1403  0.771
Show low-probability matches.